An individualized prognostic signature and multi-omics distinction for early stage hepatocellular carcinoma patients with surgical resection

Previously reported prognostic signatures for predicting the prognoses of postsurgical hepatocellular carcinoma (HCC) patients are commonly based on predefined risk scores, which are hardly applicable to samples measured by different laboratories. To solve this problem, using gene expression profile...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Ao, Lu, Song, Xuekun, Li, Xiangyu, Tong, Mengsha, Guo, You, Li, Jing, Li, Hongdong, Cai, Hao, Li, Mengyao, Guan, Qingzhou, Yan, Haidan, Guo, Zheng
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5029687/
https://ncbi.nlm.nih.gov/pubmed/27006471
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8212
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados